MicroRNA‑133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin‑bundling protein 1 Retraction in /10.3892/mmr.2021.12185

Lai,Chen; Chen,Zihua; Li,Ruixin

doi:10.3892/mmr.2015.3545

MicroRNA‑133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin‑bundling protein 1

Retraction in: /10.3892/mmr.2021.12185

Authors:
- Chen Lai
- Zihua Chen
- Ruixin Li
View Affiliations

Affiliations: Department of General Surgery, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China
Published online on: March 24, 2015 https://doi.org/10.3892/mmr.2015.3545
Pages: 1473-1478

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Fascin actin‑bundling protein 1 (FSCN1) is associated with tumor progression. In addition, deregulation of the expression of FSCN1 has been observed in certain types of cancer. However, the detailed role of FSCN1 in gastric cancer remains to be elucidated. In the present study, downregulation of microRNA (miR)‑133a and upregulation of FSCN1 were both observed in gastric cancer tissues and cell lines. Functional studies have revealed that miR‑133a is able to bind to the 3'‑untranslated region of FSCN1 mRNA, and overexpression of miR‑133a causes downregulation of FSCN1 expression, while downregulation of miR‑133a leads to an increased FSCN1 expression in gastric cancer cells. Furthermore, overexpression of miR‑133a inhibited proliferation and invasion, but promoted apoptosis of gastric cancer cells, which may be reversed by upregulation of FSCN1. By contrast, downregulation of miR‑133a enhanced proliferation and invasion, but suppressed apoptosis in gastric cancer cells. In conclusion, the anti‑oncogenic activity of miR‑133a may involve the inhibition of the target gene FSCN1. The present study suggested that miR‑133a may be a potential therapeutic target in the treatment of gastric cancer.

View Figures

View References

1	Piazuelo MB and Correa P: Gastric cancer: Overview. Colomb Med (Cali). 44:192–201. 2013.
2	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
3	Kuo CY, Chao Y and Li CP: Update on treatment of gastric cancer. J Chin Med Assoc. 77:345–353. 2014. View Article : Google Scholar : PubMed/NCBI
4	Piazuelo MB and Correa P: Gastric cancer: Overview. Colomb Med (Cali). 44:192–201. 2013.
5	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
6	Li PF, Chen SC, Xia T, et al: Non-coding RNAs and gastric cancer. World J Gastroenterol. 20:5411–5419. 2014. View Article : Google Scholar : PubMed/NCBI
7	Bartel DP: MicroRNAs: genomics, biogenesis, mechanism and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
8	Hung CH, Chiu YC, Chen CH and Hu TH: MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression and therapeutic target. BioMed Res Int. 2014:4864072014. View Article : Google Scholar
9	Qiu T, Zhou X, Wang J, et al: MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer. FEBS Lett. 588:1168–1177. 2014. View Article : Google Scholar : PubMed/NCBI
10	Wang LK, Hsiao TH, Hong TM, et al: MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma. PLoS One. 9:e967652014. View Article : Google Scholar : PubMed/NCBI
11	Guo J, Xia B, Meng F and Lou G: miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor. Tumour Biol. 35:1557–1564. 2014. View Article : Google Scholar
12	Fujiwara T, Katsuda T, Hagiwara K, et al: Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells. Stem Cells. 32:959–973. 2014. View Article : Google Scholar : PubMed/NCBI
13	Akanuma N, Hoshino I, Akutsu Y, et al: MicroRNA-133a regulates the mRNAs of two invadopodia-related proteins, FSCN1 and MMP14, in esophageal cancer. Br J Cancer. 110:189–198. 2014. View Article : Google Scholar :
14	Jayo A and Parsons M: Fascin: a key regulator of cytoskeletal dynamics. Int J Biochem Cell Biol. 42:1614–1617. 2010. View Article : Google Scholar : PubMed/NCBI
15	Yang S, Huang FK, Huang J, et al: Molecular mechanism of fascin function in filopodial formation. J Biol Chem. 288:274–284. 2013. View Article : Google Scholar :
16	Bi JB, Zhu Y, Chen XL, et al: The role of fascin in migration and invasion of urothelial carcinoma of the bladder. Urol Int. 91:227–235. 2013. View Article : Google Scholar : PubMed/NCBI
17	Tan VY, Lewis SJ, Adams JC and Martin RM: Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis. BMC Med. 11:522013. View Article : Google Scholar : PubMed/NCBI
18	Tsai WC, Jin JS, Chang WK, et al: Association of cortactin and fascin-1 expression in gastric adenocarcinoma: correlation with clinicopathological parameters. J Histochem Cytochem. 55:955–962. 2007. View Article : Google Scholar : PubMed/NCBI
19	Fu H, Hu Z, Wen J, Wang K and Liu Y: TGF-beta promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways. Acta Biochim Biophys Sin (Shanghai). 41:648–656. 2009. View Article : Google Scholar
20	Fu H, Wen JF, Hu ZL, Luo GQ and Ren HZ: Knockdown of fascin1 expression suppresses the proliferation and metastasis of gastric cancer cells. Pathology. 41:655–660. 2009. View Article : Google Scholar : PubMed/NCBI
21	Chen MB, Wei MX, Han JY, et al: MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer. Cell Signal. 26:102–109. 2014. View Article : Google Scholar
22	Adammek M, Greve B, Kässens N, et al: MicroRNA miR-145 inhibits proliferation, invasiveness and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors. Fertil Steril. 99:1346–1355. e52013. View Article : Google Scholar
23	Yamamoto H, Kohashi K, Fujita A and Oda Y: Fascin-1 over-expression and miR-133b downregulation in the progression of gastrointestinal stromal tumor. Mod Pathol. 26:563–571. 2013. View Article : Google Scholar
24	Chiyomaru T, Enokida H, Tatarano S, et al: miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer. 102:883–891. 2010. View Article : Google Scholar : PubMed/NCBI
25	Kano M, Seki N, Kikkawa N, et al: miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer. 127:2804–2814. 2010. View Article : Google Scholar
26	Wu ZS, Wang CQ, Xiang R, et al: Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion. BMC Cancer. 12:512012. View Article : Google Scholar : PubMed/NCBI